Table 6

ALD-related PPPM healthcare costs among Medicaid beneficiaries with HCV and ALD (cases), by ALD type at index ALD diagnosis
Index diagnosis
Variables All ALD-related costs1 Decompensated cirrhosis Hepatocellular carcinoma P-value2
N 1193 1098 73
Inpatient
Mean (SD) $1,272 ($2,926) $1,242 ($2,806) $2,093 ($4,539) 0.624
Median $0 $0 $0
IQR $0-$1,006 $0-$1,056 $0-$1,155
Outpatient
Mean (SD) $83 ($184) $76 ($168) $202 ($341) 0.051
Median $23 $23 $37
IQR $6-$79 $7-$78 $8-$157
Other costs3
Mean (SD) $1 ($11) $1 ($11) $2 ($10) <.001
Median $0 $0 $0
IQR $0-$0 $0-$0 $0-$0
Total costs4
Mean (SD) $1,356 ($2,981) $1,319 ($2,848) $2,297 ($4,700) 0.807
Median $88 $96 $67

Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.

Notes: All costs are inflated to 2009 USD using the Medical Care component of the CPI. Costs over the entire follow-up period were divided by the number of eligible patient months to create the PPPM cost estimates.

1 “ALD-Related Costs” includes all patients with HCV and ALD, including 22 patients whose index ALD diagnosis was a transplant procedure or history of transplant.

2 Calculated with the Wilcoxon test for comparison of means.

3 "Other" costs include nursing home, home health, hospice, and other services.

4 "Total costs" include inpatient, outpatient, pharmacy, and other (nursing home, home health, hospice, and other services) costs. Pharmacy and other costs comprised < $5 of mean total ALD-related costs in each cohort.

ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.

Menzin et al.

Menzin et al. BMC Health Services Research 2012 12:459   doi:10.1186/1472-6963-12-459

Open Data